J. Burton

发表

Gender and acute myocardial infarction: is there a different response to thrombolysis?

R. Califf, E. Topol, H. White, 1997, Journal of the American College of Cardiology.

Can Symptom Presentation Predict Unstable Angina/Non-ST-Segment Elevation Myocardial Infarction in a Moderate-Risk Cohort?

J. Burton, Ann Comeau, L. Jensen, 2006, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

Coronary bypass graft fate. Angiographic study of 1,179 vein grafts early, one year, and five years after operation.

W. Keon, J. Burton, G. Fitzgibbon, 1986, The Journal of thoracic and cardiovascular surgery.

Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years.

W J Keon, W. Keon, J. Burton, 1996, Journal of the American College of Cardiology.

Aortocoronary Bypass Surgery in “Asymptomatic” Patients with Coronary Artery Disease

W. Keon, J. Burton, G. Fitzgibbon, 1984 .

Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct-related coronary artery on left ventricular function in patients with a recent (< 6 weeks) Q-wave acute myocardial infarction (Total Occlusion Post-Myocardial Infarction Intervention Study [TOMIIS]--a pilot study).

R F Davies, K. Teo, T. Ruddy, 1994, The American journal of cardiology.

Who Should Receive HMG CoA Reductase Inhibitors?

K. Teo, J. Burton, 2012, Drugs.

Perioperative myocardial infarction complicating coronary bypass. Clinical and angiographic correlations and prognosis.

W. Keon, J. Burton, G. Fitzgibbon, 1981, The Journal of thoracic and cardiovascular surgery.

Aorta-coronary bypass in patients with coronary artery disease who do not have angina.

W. Keon, J. Burton, G. Fitzgibbon, 1984, The Journal of thoracic and cardiovascular surgery.

Prevention and regression of coronary atherosclerosis. Is it safe and efficacious therapy?

K. Teo, T. Montague, R. Tsuyuki, 1994, Chest.

Coronary Bypass Graft Fate: Angiographic Grading of 1400 Consecutive Grafts Early after Operation and of 1132 after One Year

J. Burton, G. Fitzgibbon, A. Leach, 1978, Circulation.

2001 Canadian Cardiovascular Society Consensus Conference on cardiac transplantation.

M. Carrier, P. Hendry, A. Menkis, 2003, The Canadian journal of cardiology.

What is the frequency and functional and clinical significance of complex lesions in non-infarct-related arteries after fibrinolysis for acute ST-elevation myocardial infarction?

P. Armstrong, F. Van de Werf, Yuling Fu, 2006, American heart journal.

Prompt improvement of left ventricular function and preservation of topography with combined reperfusion and intravenous nitroglycerin in acute myocardial infarction.

J. Burton, B. Jugdutt, W. Tymchak, 1997, Cardiology.

Changes in acute myocardial infarction risk and patterns of practice for patients older and younger than 70 years, 1987-90.

K. Teo, T. Montague, D. Catellier, 1992, The Canadian journal of cardiology.

Collaborative angiographic patency trial of recombinant staphylokinase (CAPTORS).

P. Armstrong, F. Van de Werf, K. Teo, 2000, American heart journal.

Early angiography cannot predict postthrombolytic coronary reocclusion: observations from the GUSTO angiographic study. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.

R. Califf, E. Topol, M. Simoons, 1994, Journal of the American College of Cardiology.

The Molecular Phenotype of Heart Transplant Biopsies: Relationship to Histopathological and Clinical Variables

K. Famulski, P. Halloran, L. Hidalgo, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Vasodilator Therapy in Acute Myocardial Infarction: A Comparison of Sodium Nitroprusside and Nitroglycerin

P. Armstrong, J. Burton, J. Parker, 1975, Circulation.

Cyclosporine reduction in the presence of everolimus: 3-month data from a Canadian pilot study of maintenance cardiac allograft recipients.

A. Ignaszewski, H. Ross, M. White, 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Compromised atrial coronary anatomy is associated with atrial arrhythmias and atrioventricular block complicating acute myocardial infarction.

P. Armstrong, Yuling Fu, J. Burton, 2005, Journal of electrocardiology.

Implication of transstenotic coronary pressure gradient measurement during coronary angioplasty.

J. Burton, M. Haraphongse, R. E. Rossall, 1986, Catheterization and cardiovascular diagnosis.

Comparative effects of lidocaine and procainamide on acutely impaired hemodynamics.

P. Armstrong, J. Burton, M. Mathew, 1976, The American journal of medicine.

Interventions for coronary stenosis--a Canadian experience of 30 revolutionary years.

J. Burton, G. Fitzgibbon, A. Leach, 1996, The Canadian journal of cardiology.

Clinical efficacy of emergency bypass surgery for failed coronary angioplasty.

T. Montague, J. Burton, M. Haraphongse, 1990, The Canadian journal of cardiology.

Rationale and design features of a clinical trial examining the effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT). SCAT Investigators.

K. Teo, C. Buller, T. Montague, 1997, The Canadian journal of cardiology.

Changing practice patterns in the management of acute myocardial infarction complicated by cardiogenic shock: elderly compared with younger patients.

K. Teo, A. Ignaszewski, V. Džavík, 1998, The Canadian journal of cardiology.

Post-traumatic renal failure in military personnel in Southeast Asia. Experience at Clark USAF hospital, Republic of the Philippines.

J. Burton, R. Lordon, 1972, The American journal of medicine.

Effect of nitroglycerin ointment on the clinical and hemodynamic response to exercise.

P. Armstrong, J. Burton, J. Parker, 1976, The American journal of cardiology.

Effects of long term cholesterol lowering on coronary atherosclerosis in patient risk factor subgroups: the Simvastatin/enalapril Coronary Atherosclerosis Trial (SCAT).

K. Teo, C. Buller, T. Montague, 2003, The Canadian journal of cardiology.

Clopidogrel-Precipitated Rhabdomyolysis in a Stable Heart Transplant Patient

J. Burton, G. Pearson, I. Burton, 2007, The Annals of pharmacotherapy.

An approach to pericardial effusion in hemodialysis patients.

G. W. Smith, J. Burton, D. Caralis, 1973, The Johns Hopkins medical journal.

Long-Term Effects of Cholesterol Lowering and Angiotensin-Converting Enzyme Inhibition on Coronary Atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT)

K. Teo, C. Buller, T. Montague, 2000, Circulation.

Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial

R. Califf, D. Mark, E. Topol, 1999, The Lancet.

Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion.

N. Giannetti, S. Busque, A. Ignaszewski, 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Angiographic core laboratory reproducibility analyses: implications for planning clinical trials using coronary angiography and left ventriculography end-points

C. Buller, M. Schulzer, T. Steigen, 2008, The International Journal of Cardiovascular Imaging.

Risk stratification after percutaneous transluminal coronary angioplasty

J. Burton, M. Haraphongse, R. E. Rossall, 1990, Cardiovascular Drugs and Therapy.

Effect of bare metal stenting on angiographic and clinical outcomes in diabetic and nondiabetic patients undergoing percutaneous coronary intervention of nonacute occluded coronary arteries: A report from the total occlusion study of Canada (TOSCA)

K. Teo, C. Buller, D. Catellier, 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial.

Yinghua Su, D. Stewart, D. Fitchett, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

VEGF Gene Therapy Fails to Improve Perfusion of Ischemic Myocardium in Patients With Advanced Coronary Disease: Results of the NORTHERN Trial.

Yinghua Su, D. Stewart, D. Fitchett, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

Effect of serum lipid concentrations on restenosis after successful de novo percutaneous transluminal coronary angioplasty in patients with total cholesterol 160 to 240 mg/dl and triglycerides < 350 mg/dl.

K. Teo, T. Montague, S. Yokoyama, 1995, The American journal of cardiology.

52 Reduction of Cardiac Allograft Vasculopathy with Everolimus over Mycophenolate Mofetil: Intravascular Ultrasound Results of a Randomized Multicenter Trial

R. Starling, J. Kobashigawa, H. Ross, 2011 .

QT Interval Prolongation as Predictor of Sudden Death in Patients with Myocardial Infarction

J. Burton, G. Fitzgibbon, A. Leach, 1978 .

Subclinical Inflammation and Prothrombotic State in Heart Transplant Recipients: Impact of Cyclosporin Microemulsion vs. Tacrolimus

N. Giannetti, H. Ross, M. White, 2006, Transplantation.